Doximity (DOCS) Fell as Guidance Fell Short of Expectations
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Growth Fund” fourth-quarter 2025 investor letter. A copy of the same can be downloaded here. U.S.
Doximity Inc. (DOCS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bayforest Capital Theodoros Tsagaris | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $34.50 | 2,950 | $101,775.00 | 252,950 | 2022-05-27 | Filing | |
| $32.19 | 15,000 | $482,863.50 | 197,676 | 2022-05-20 | Filing | |
| $26.00 | 775,000 | $20,150,000.00 | 775,000 | 2021-06-28 | Filing | |
| $26.00 | 775,000 | $20,150,000.00 | 775,000 | 2021-06-28 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $44.65 | 2,000 | $89,300.00 | 19,839 | 2026-01-02 | Filing | |
| $50.71 | 2,000 | $101,420.00 | 19,839 | 2025-12-01 | Filing | |
| $50.00 | 10,000 | $500,000.00 | 3,221 | 2025-11-21 | Filing | |
| $66.44 | 2,000 | $132,880.00 | 19,839 | 2025-11-03 | Filing | |
| $70.84 | 5,000 | $354,200.00 | 19,839 | 2025-10-10 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,711,340 | $164,338,135 | 0.14% | |
| 2. | 557,793 | $24,699,074 | 0.57% | |
| 3. | 528,578 | $23,405,422 | 0.44% | |
| 4. | 456,701 | $20,222,720 | 0.11% | |
| 5. | 380,338 | $16,841,367 | 0.05% |
News See All
Overweight Doximity (DOCS) Position Weighs on Fund Performance
Voya Investment Management’s Voya MidCap Opportunities Fund released its Q4 2025 investor letter, titled “Seeking a More Favorable Risk/Return Trade-off”, outlining a quarter marked by solid market...
Raymond James Sees ‘Knee-Jerk’ AI Reaction, Reaffirms Strong Buy on Doximity, Inc. (DOCS)
Doximity, Inc. (NYSE:DOCS) is among the most promising growth stocks according to analysts. On January 9, Raymond James reaffirmed a ‘Strong Buy’ rating on Doximity, Inc.
13 Most Promising Growth Stocks According to Analysts
In today's market, shaped by continuous innovation and evolving macro backdrops, investors are wondering: which stocks to invest in? While many believe in investing in low-risk stocks, a large proportion...
Doximity (DOCS) Slid on Renewed Volatility
ClearBridge Investments, an investment management company, released its “ClearBridge Growth Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Morgan Stanley Views Doximity (DOCS) Underperformance as Attractive Entry Point Amid Strong Engagement
Doximity Inc. (NYSE:DOCS) is one of the oversold stocks to buy now.
10 Oversold Stocks to Buy Now
On January 6, Dan Greenhaus of Solus Alternative Asset Management, Cameron Dawson of NewEdge Wealth, and Sonali Basak of iCapital appeared on CNBC’s 'Closing Bell' to discuss what investors should be...
Why BofA Sees Strong Upside for Doximity (DOCS)
On December 16, Bank of America analyst Allen Lutz reiterated his bullish stance on Doximity (NYSE:DOCS). He assigned a Buy rating to the stock with a $82 price target.
15 Most Promising Mid-Cap Healthcare Stocks Under $50
Traditionally, healthcare stocks have been considered defensive, offering strong immunity to business cycles.
Morgan Stanley Stays Neutral on Doximity, Highlights Strength in Video Module Business
On November 3, 2025, Morgan Stanley maintained its Equal-Weight rating on Doximity and held its price target steady at $62.
Hedge Fund Resource Center Billionaire Hedge Funds
